Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy explained: symptoms, causes, diagnosis, treatment options, and when to seek specialist heart care.

Quick answer
Hypertrophic cardiomyopathy is a disease in which the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively and sometimes causing rhythm problems. Treatment depends on symptoms and the degree of obstruction, and at Acibadem it may include detailed cardiac evaluation, medication, rhythm monitoring, minimally invasive procedures, or surgery when needed.
Hypertrophic Cardiomyopathy is a heart muscle disease in which the heart muscle, most often the wall between the two lower chambers, becomes abnormally thick. This thickening can make it harder for the heart to fill and pump normally and may sometimes disturb the heart rhythm.
Overview
Hypertrophic Cardiomyopathy is a condition in which part of the heart muscle becomes thicker than expected without another clear cause, such as long-standing uncontrolled high blood pressure or severe valve narrowing. The thickening most often affects the septum, the wall that separates the left and right lower chambers of the heart. When this area becomes enlarged, it may narrow the pathway where blood leaves the heart, a pattern called obstructive Hypertrophic Cardiomyopathy.
The condition is often genetic, meaning it can run in families. However, its effects vary widely. One person may have no symptoms and live normally with regular monitoring, while another may need medicines, procedures, or a device to manage symptoms or heart rhythm risk. The thickness of the heart muscle alone does not tell the whole story; specialists also consider symptoms, rhythm findings, family history, blood flow obstruction, and overall heart function.
Hypertrophic Cardiomyopathy can occur in children, teenagers, and adults. It is sometimes discovered during evaluation for a heart murmur, fainting, chest discomfort, shortness of breath, an abnormal electrocardiogram, or family screening after a relative is diagnosed. Early and accurate diagnosis is valuable because it allows the care team to guide exercise, monitor rhythm, screen relatives, and choose treatment when needed.
Symptoms

Hypertrophic Cardiomyopathy symptoms can be mild, intermittent, or absent. Some people are diagnosed only because a family member has the condition or because a routine test shows an abnormal heart tracing. Others notice symptoms during exertion, dehydration, emotional stress, or after large meals, because these situations can change heart filling and blood flow.
Common symptoms include breathlessness, especially with activity; chest pressure or discomfort; fast, pounding, or irregular heartbeats; reduced exercise tolerance; dizziness; and fainting. Some people may also experience tiredness, swelling of the legs, or symptoms related to atrial fibrillation, an irregular rhythm that can cause palpitations and shortness of breath.
- Shortness of breath during exercise or when lying down
- Chest discomfort, pressure, or tightness
- Palpitations or a sensation of skipped beats
- Lightheadedness, near-fainting, or fainting
- Unexplained fatigue or reduced stamina
Symptoms do not always match the severity of the condition. A person with significant muscle thickening may feel well, while someone with a smaller degree of thickening may have troublesome symptoms if blood flow is obstructed or heart rhythm is affected. This is why structured cardiology assessment is important even when symptoms appear minor.
Causes & Risk Factors
Hypertrophic Cardiomyopathy is most often caused by inherited changes in genes that help build the heart muscle. These genetic changes can affect the way heart muscle fibers are organized, leading to thickening, stiffness, and sometimes scarring within the heart. The inheritance pattern is commonly autosomal dominant, which means a child of an affected parent may have a chance of inheriting the gene change, although not everyone who inherits it develops the same degree of disease.
A family history of Hypertrophic Cardiomyopathy, unexplained fainting, heart rhythm problems, or sudden cardiac death at a young age can increase suspicion for the condition. However, some people are the first in their family to be diagnosed because the gene change is new, relatives were never tested, or earlier generations had mild or unrecognized disease.
Risk factors for symptoms or complications are assessed individually. They may include a history of fainting, certain abnormal heart rhythms, marked heart muscle thickness, reduced pumping function, significant obstruction to blood leaving the heart, scarring seen on cardiac MRI, or a family history of sudden cardiac death related to HCM. These factors do not automatically mean a serious outcome will occur, but they help specialists decide how closely to monitor the patient and whether preventive treatment is appropriate.
It is also important to distinguish Hypertrophic Cardiomyopathy from other causes of a thickened heart muscle. Long-standing high blood pressure, athletic training, aortic valve disease, and some metabolic or storage disorders can also produce thickening. A cardiologist uses imaging, medical history, family information, and sometimes genetic testing to clarify the diagnosis.
Diagnosis
Diagnosis of Hypertrophic Cardiomyopathy begins with a medical history, family history, physical examination, and heart tests. A clinician may listen for a murmur, ask about exercise symptoms, fainting, palpitations, and relatives with heart disease, and review any previous electrocardiograms or imaging. Because HCM can be inherited, family information is a central part of the evaluation.
The main imaging test is echocardiography, a heart ultrasound that shows muscle thickness, chamber size, valve movement, and whether blood flow is obstructed. An electrocardiogram records the heart’s electrical pattern and may show thickening, rhythm disturbances, or repolarization changes. Ambulatory rhythm monitoring, such as a wearable monitor used for one or more days, can detect intermittent arrhythmias that may not appear during a brief clinic test.
Cardiac MRI may be recommended when ultrasound images are limited or when the specialist needs more detail about the heart muscle, scarring, or areas of thickening. Exercise testing can help assess blood pressure response, symptoms, rhythm behavior, and exercise capacity under supervised conditions. Blood tests may be used to evaluate related issues, but they do not by themselves diagnose HCM.
Genetic counseling and genetic testing may be offered, especially when the diagnosis is clear or there is a family history. If a disease-causing gene change is found, close relatives can be offered targeted testing and heart screening. If genetic testing is negative, relatives may still need clinical screening, because not all genetic causes are currently identifiable.
Treatment Options
Hypertrophic Cardiomyopathy treatment is individualized. The right approach is decided by a cardiologist or HCM specialist after assessment of symptoms, heart muscle thickness, blood flow obstruction, rhythm findings, family history, and overall health. Treatment aims to relieve symptoms, reduce rhythm-related risk, prevent complications, and support safe daily activity.
For people with symptoms caused by obstruction or impaired heart filling, medicines may be used to slow the heart rate, improve filling time, reduce palpitations, or manage rhythm problems. Some patients with atrial fibrillation may need treatment to control rhythm or heart rate and reduce the risk of blood clots. Medication choices depend on blood pressure, heart rhythm, obstruction severity, other conditions, and tolerance, so they should be guided and reviewed by a qualified doctor.
When symptoms remain significant despite appropriate medical care and there is clear obstruction, specialist procedures may be considered. Septal reduction therapy can reduce the thickness of the obstructing septum and improve blood flow in carefully selected patients. This may involve surgery to remove a small portion of thickened muscle or a catheter-based procedure that reduces the obstructing tissue. These treatments require detailed evaluation at experienced cardiac centers.
Some people with a higher assessed risk of dangerous heart rhythms may benefit from an implantable cardioverter-defibrillator, a device that monitors rhythm and can treat life-threatening rhythm disturbances. Other parts of care may include lifestyle guidance, supervised exercise advice, rhythm monitoring, treatment of high blood pressure or sleep apnea when present, and family screening. Follow-up is usually long term because symptoms and risk profile can change over time.
Living With / Prognosis
Many people with Hypertrophic Cardiomyopathy live active, fulfilling lives with regular medical follow-up. Prognosis depends on the type of HCM, symptom burden, rhythm findings, degree of obstruction, heart function, and personal risk factors. With modern imaging, rhythm monitoring, device therapy when needed, and specialist procedures for selected patients, care can be tailored to the individual.
Daily living advice usually focuses on consistency and prevention of avoidable triggers. Patients are often advised to stay well hydrated, avoid sudden extreme exertion without medical guidance, discuss competitive sports participation with a cardiologist, and seek advice before using medicines or supplements that may affect heart rate, blood pressure, or hydration. Alcohol excess and stimulant use may worsen palpitations or rhythm problems in some patients.
Exercise is not automatically forbidden, but recommendations should be personalized. Many people can take part in moderate recreational activity, while others need restrictions depending on symptoms, obstruction, arrhythmias, or previous fainting. A cardiologist can help define safe activity levels and may recommend supervised exercise testing before giving detailed advice.
Emotional and family support also matters because HCM can affect relatives and may raise concerns about inherited risk. Genetic counseling, family screening, and clear communication can help relatives understand whether they need evaluation. For international patients, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can support diagnosis and treatment planning for Hypertrophic Cardiomyopathy within a coordinated heart care setting.
When to See a Doctor
A person should see a doctor if they have unexplained shortness of breath, chest discomfort, palpitations, fainting, or reduced exercise tolerance, especially if symptoms occur during or after physical activity. Medical evaluation is also important when there is a known family history of Hypertrophic Cardiomyopathy, sudden unexplained death at a young age, or inherited heart rhythm disease.
Urgent medical care is needed for fainting during exercise, chest pain that is severe or persistent, sudden severe breathlessness, or palpitations with dizziness, weakness, or near-fainting. These symptoms do not always mean a dangerous event is occurring, but prompt assessment helps identify rhythm problems, obstruction, or other heart conditions that need treatment.
People already diagnosed with HCM should keep regular cardiology follow-up even when they feel well. Follow-up visits may include updated imaging, rhythm monitoring, medication review, and risk reassessment. Patients should also ask their doctor how often relatives should be screened and whether genetic counseling is appropriate for the family.
Frequently asked questions
What is Hypertrophic Cardiomyopathy?
Hypertrophic Cardiomyopathy is a disease of the heart muscle in which the muscle becomes abnormally thick, most often in the wall between the lower heart chambers. The thickened muscle can make the heart stiffer and may sometimes block blood flow out of the heart. It can also be associated with abnormal heart rhythms.
Is Hypertrophic Cardiomyopathy inherited?
In many cases, Hypertrophic Cardiomyopathy is inherited through a gene change that affects heart muscle proteins. It can run in families, although severity can differ greatly between relatives. Genetic counseling and family screening can help identify who may need monitoring.
Can someone have HCM without symptoms?
Yes. Some people with HCM feel completely well and are diagnosed only after a heart test, a murmur, or screening because a relative has the condition. Even without symptoms, regular follow-up is important because heart structure and rhythm findings can change over time.
How is Hypertrophic Cardiomyopathy diagnosed?
Diagnosis usually involves an echocardiogram, which is an ultrasound of the heart, and an electrocardiogram to assess electrical activity. A cardiologist may also recommend rhythm monitoring, cardiac MRI, exercise testing, or genetic testing. The diagnosis is based on the full clinical picture, not one test alone.
What treatments are available for Hypertrophic Cardiomyopathy?
Treatment may include lifestyle guidance, medicines to improve symptoms or manage rhythm problems, implantable devices for selected higher-risk patients, and procedures to reduce obstruction in carefully chosen cases. The best option depends on symptoms, test results, and individual risk assessment. A specialist should decide the treatment plan after a detailed evaluation.
Can people with HCM exercise?
Many people with HCM can do some form of physical activity, but the type and intensity should be discussed with a cardiologist. Recommendations depend on symptoms, obstruction, rhythm findings, previous fainting, and overall risk. Supervised exercise testing may help guide safe activity advice.
Should family members be tested if one person has HCM?
Yes, close relatives are usually advised to have clinical screening because HCM can be inherited. Screening may include a medical history, electrocardiogram, echocardiogram, and sometimes genetic testing if a gene change has been found in the family. The timing and frequency of screening should be guided by a cardiologist or genetic counselor.
References
- American Heart Association
- European Society of Cardiology
- American College of Cardiology
- National Heart, Lung, and Blood Institute
- GeneReviews
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Treatments for This Condition
Doctors Who Treat This Condition

Prof. Dr. Ahmet Tulga Ulus
Cardiovascular Surgery
Prof. Dr. Ahmet Ümit Güllü
Cardiovascular Surgery
Prof. Dr. Bülent Kisacikoğlu
Cardiovascular Surgery
Prof. Dr. Cem Alhan
Cardiovascular Surgery
Prof. Dr. Ersin Erek
Cardiovascular Surgery
Prof. Dr. Eyüp Murat Ökten
Cardiovascular Surgery
Prof. Dr. Fuat Bilgen
Cardiovascular Surgery
Prof. Dr. Hayati Özkan
Cardiovascular Surgery
Prof. Dr. Mehmet Özkan
Cardiovascular Surgery
Prof. Dr. Rıza Türköz
Cardiovascular Surgery
Prof. Dr. Tayyar Sarioğlu
Cardiovascular Surgery
Prof. Dr. Öner Gülcan
Cardiovascular SurgeryRelated Articles

CABG Recovery in Older Adults: What Families Should Expect

Pulmonary Hypertension: What Happens If It Goes Untreated?

Cardiovascular Toxicology: How Drugs and Toxins Can Damage the Heart

Peripheral Artery Disease: Leg Pain, Poor Circulation, and When Angioplasty Helps

Kawasaki Disease in Adults: Can Childhood Heart Changes Appear Later?

Arrhythmia Symptoms That Need Urgent Evaluation Instead of Watchful Waiting

Hyperlipidemia: When High Cholesterol Needs Specialist Cardiology Care

Deep Vein Thrombosis After Travel: Why Long Flights Raise the Risk

Stent Procedure Cost in Turkey: What Can Change the Total Price?

Heart Valve Surgery Recovery: ICU Stay, Walking, and Returning Home

Peripheral Artery Disease vs Deep Vein Thrombosis: How to Tell the Difference

